| Sekinah Charlton, PHARMD | |
|
2102 Nez Perce Dr, Lewiston, ID 83501-4116 | |
| (208) 743-4434 | |
| Not Available |
| Full Name | Sekinah Charlton |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2102 Nez Perce Dr, Lewiston, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114277852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | IR60225984 (Washington) | Secondary |
| 183500000X | Pharmacist | E18570 (Idaho) | Secondary |
| 183500000X | Pharmacist | P8337 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sekinah Charlton, PHARMD 2102 Nez Perce Dr, Lewiston, ID 83501-4116 Ph: (208) 743-4434 | Sekinah Charlton, PHARMD 2102 Nez Perce Dr, Lewiston, ID 83501-4116 Ph: (208) 743-4434 |
News Archive
Having diabetes may cause women to experience a greater degree of hearing loss as they age, especially if the metabolic disorder is not well controlled with medication, according to a new study from Henry Ford Hospital in Detroit.
ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.
The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
A new brain connectivity study from Penn Medicine published today in the Proceedings of National Academy of Sciences found striking differences in the neural wiring of men and women that's lending credence to some commonly-held beliefs about their behavior.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has accepted for review the complete response submission made by Endo to the new drug application for its long-acting testosterone undecanoate injection, AVEED, intended for men diagnosed with hypogonadism.
› Verified 6 days ago
Nicholas Rodighiero, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1904 19th Ave, Lewiston, ID 83501 Phone: 208-743-9127 Fax: 208-743-4777 | |
Ms. Marsha D Goeckner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 338 6th St, Suite 101, Lewiston, ID 83501 Phone: 208-848-8290 Fax: 208-848-8291 | |
Mrs. Laura D Heitzman, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 523 Thain Rd, Lewiston, ID 83501 Phone: 208-743-5515 Fax: 208-743-0333 | |
Jeff J Schmidt, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1815 21st St, Lewiston, ID 83501 Phone: 208-746-5955 Fax: 208-746-0685 | |
Mr. Richard Byron Robertson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2330 Nez Perce Dr, Lewiston, ID 83501 Phone: 208-798-0481 Fax: 208-798-0715 | |
Amanda Marie Mcgehee, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 523 Thain Rd, Lewiston, ID 83501 Phone: 208-743-5515 |